鲍曼不动杆菌血症的危险因素评估、经验性抗菌治疗及其对患者预后的影响 - Suppr

Evaluation of Risk Factors and Empiric Antimicrobial Therapy for Acinetobacter baumannii Bacteremia and Impact on Patient Outcomes.

作者信息

Morrisette Taylor, Mitchell Chelsea N, Cutshall B Tate, Twilla Jennifer D

机构信息

Department of Clinical Pharmacy Skaggs School of Pharmacy and Pharmaceutical Sciences University of Colorado Aurora, CO.

Department of Clinical Pharmacy Froedtert Hospital Milwaukee, WI.

出版信息

Am J Ther. 2019 Nov/Dec;26(6):e778-e780. doi: 10.1097/MJT.0000000000000949.

DOI:10.1097/MJT.0000000000000949

PMID:30839321

Abstract

摘要

相似文献

Evaluation of Risk Factors and Empiric Antimicrobial Therapy for Acinetobacter baumannii Bacteremia and Impact on Patient Outcomes.

Am J Ther. 2019 Nov/Dec;26(6):e778-e780. doi: 10.1097/MJT.0000000000000949.

Risk factors and clinical outcomes of multidrug-resistant Acinetobacter baumannii bacteremia at a university hospital in Thailand.

Southeast Asian J Trop Med Public Health. 2011 May;42(3):693-703.

Carbapenem-resistant versus carbapenem-susceptible Acinetobacter baumannii bacteremia in a Greek intensive care unit: risk factors, clinical features and outcomes.

Infection. 2010 Jun;38(3):173-80. doi: 10.1007/s15010-010-0008-1. Epub 2010 Mar 12.

[Acinetobacter baumannii bacteremia: clinical and prognostic features].

Enferm Infecc Microbiol Clin. 2003 May;21(5):242-7. doi: 10.1016/s0213-005x(03)72930-9.

Risk and Prognostic Factors for Multidrug-Resistant Acinetobacter Baumannii Complex Bacteremia: A Retrospective Study in a Tertiary Hospital of West China.

PLoS One. 2015 Jun 17;10(6):e0130701. doi: 10.1371/journal.pone.0130701. eCollection 2015.

Community-acquired bloodstream infections caused by Acinetobacter baumannii: A matched case-control study.

J Microbiol Immunol Infect. 2018 Oct;51(5):629-635. doi: 10.1016/j.jmii.2017.02.004. Epub 2017 Jun 29.

Are we closing in on an "elusive enemy"? The current status of our battle with Acinetobacter baumannii.

Virulence. 2011 Mar-Apr;2(2):86-90. doi: 10.4161/viru.2.2.15748.

Antimicrobial resistance profiles and associated factors of Acinetobacter and Pseudomonas aeruginosa nosocomial infection among patients admitted at Dessie comprehensive specialized Hospital, North-East Ethiopia. A cross-sectional study.

PLoS One. 2021 Nov 15;16(11):e0257272. doi: 10.1371/journal.pone.0257272. eCollection 2021.

A multicenter study of risk factors and outcome of hospitalized patients with infections due to carbapenem-resistant Acinetobacter baumannii.

Int J Infect Dis. 2010 Sep;14(9):e764-9. doi: 10.1016/j.ijid.2010.02.2254. Epub 2010 Jun 19.

Confronting multidrug-resistant Acinetobacter baumannii: a review.

Int J Antimicrob Agents. 2011 Feb;37(2):102-9. doi: 10.1016/j.ijantimicag.2010.10.014. Epub 2010 Dec 4.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Evaluation of Risk Factors and Empiric Antimicrobial Therapy for Acinetobacter baumannii Bacteremia and Impact on Patient Outcomes.

作者信息

Morrisette Taylor, Mitchell Chelsea N, Cutshall B Tate, Twilla Jennifer D

机构信息

Department of Clinical Pharmacy Skaggs School of Pharmacy and Pharmaceutical Sciences University of Colorado Aurora, CO.

Department of Clinical Pharmacy Froedtert Hospital Milwaukee, WI.

出版信息

Am J Ther. 2019 Nov/Dec;26(6):e778-e780. doi: 10.1097/MJT.0000000000000949.

DOI:10.1097/MJT.0000000000000949

PMID:30839321

Abstract

摘要

相似文献

Evaluation of Risk Factors and Empiric Antimicrobial Therapy for Acinetobacter baumannii Bacteremia and Impact on Patient Outcomes.

Am J Ther. 2019 Nov/Dec;26(6):e778-e780. doi: 10.1097/MJT.0000000000000949.

Risk factors and clinical outcomes of multidrug-resistant Acinetobacter baumannii bacteremia at a university hospital in Thailand.

Southeast Asian J Trop Med Public Health. 2011 May;42(3):693-703.

Carbapenem-resistant versus carbapenem-susceptible Acinetobacter baumannii bacteremia in a Greek intensive care unit: risk factors, clinical features and outcomes.

Infection. 2010 Jun;38(3):173-80. doi: 10.1007/s15010-010-0008-1. Epub 2010 Mar 12.

[Acinetobacter baumannii bacteremia: clinical and prognostic features].

Enferm Infecc Microbiol Clin. 2003 May;21(5):242-7. doi: 10.1016/s0213-005x(03)72930-9.

Risk and Prognostic Factors for Multidrug-Resistant Acinetobacter Baumannii Complex Bacteremia: A Retrospective Study in a Tertiary Hospital of West China.

PLoS One. 2015 Jun 17;10(6):e0130701. doi: 10.1371/journal.pone.0130701. eCollection 2015.

Community-acquired bloodstream infections caused by Acinetobacter baumannii: A matched case-control study.

J Microbiol Immunol Infect. 2018 Oct;51(5):629-635. doi: 10.1016/j.jmii.2017.02.004. Epub 2017 Jun 29.

Are we closing in on an "elusive enemy"? The current status of our battle with Acinetobacter baumannii.

Virulence. 2011 Mar-Apr;2(2):86-90. doi: 10.4161/viru.2.2.15748.

PLoS One. 2021 Nov 15;16(11):e0257272. doi: 10.1371/journal.pone.0257272. eCollection 2021.

A multicenter study of risk factors and outcome of hospitalized patients with infections due to carbapenem-resistant Acinetobacter baumannii.

Int J Infect Dis. 2010 Sep;14(9):e764-9. doi: 10.1016/j.ijid.2010.02.2254. Epub 2010 Jun 19.

Confronting multidrug-resistant Acinetobacter baumannii: a review.

Int J Antimicrob Agents. 2011 Feb;37(2):102-9. doi: 10.1016/j.ijantimicag.2010.10.014. Epub 2010 Dec 4.

Evaluation of Risk Factors and Empiric Antimicrobial Therapy for Acinetobacter baumannii Bacteremia and Impact on Patient Outcomes.

作者信息

机构信息

出版信息

相似文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

Evaluation of Risk Factors and Empiric Antimicrobial Therapy for Acinetobacter baumannii Bacteremia and Impact on Patient Outcomes.

作者信息

机构信息

出版信息

相似文献